Alvotech(ALVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALVO Alvotech

盘后交易 10-26 19:29:51 EDT

4.62

+0.04

+0.87%

盘后4.70

+0.08+1.73%

17:36 EDT

最高4.64	最低4.52	成交量58.49万
今开4.57	昨收4.58	日振幅2.62%
总市值16.49亿	流通市值6.51亿	总股本3.57亿
成交额268.49万	换手率0.41%	流通股本1.41亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALVO","market":"US","secType":"STK","nameCN":"Alvotech","latestPrice":4.62,"timestamp":1793044800000,"preClose":4.58,"halted":0,"volume":584887,"hourTrading":{"tag":"盘后","latestPrice":4.7,"preClose":4.62,"latestTime":"17:36 EDT","volume":17923,"amount":82804.67222899999,"timestamp":1793050563868,"change":0.08,"changeRate":0.017316,"amplitude":0.036775},"delay":0,"changeRate":0.00873362445414848,"floatShares":141000000,"shares":357000000,"eps":-0.608094,"marketStatus":"盘后交易","change":0.04,"latestTime":"10-26 19:29:51 EDT","open":4.57,"high":4.64,"low":4.52,"amount":2684939.565449,"amplitude":0.026201,"askPrice":5.31,"askSize":500,"bidPrice":4.53,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.608094,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793059200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":4.58,"preHourTrading":{"tag":"盘前","latestPrice":4.6,"preClose":4.58,"latestTime":"09:28 EDT","volume":1183,"amount":5492.2770721,"timestamp":1793021309110,"change":0.02,"changeRate":0.004367,"amplitude":0.048035},"postHourTrading":{"tag":"盘后","latestPrice":4.7,"preClose":4.62,"latestTime":"17:36 EDT","volume":17923,"amount":82804.67222899999,"timestamp":1793050563868,"change":0.08,"changeRate":0.017316,"amplitude":0.036775},"volumeRatio":0.682646},"requestUrl":"/m/hq/s/ALVO","defaultTab":"news","newsList":[{"id":"1189665674","title":"Alvotech宣布美国FDA受理AVT80生物制品许可申请，推动Entyvio®生物类似药项目扩展至皮下注射剂型","url":"https://stock-news.laohu8.com/highlight/detail?id=1189665674","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189665674?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:31","pubTimestamp":1788165073,"startTime":"0","endTime":"0","summary":"Alvotech近日宣布，美国食品药品监督管理局已正式受理其针对AVT80的生物制品许可申请并进入审查程序。这一关键进展，使得该公司原已布局的Entyvio生物类似药开发计划，进一步延伸至皮下注射制剂领域。值得注意的是，FDA受理该申请意味着完成了初步的完整性审查，并非最终批准。子公司Alvotech正与多家合作伙伴协同推进这一产品线，其在生物类似药领域的战略布局日益清晰。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123885510","title":"Alvotech与Lotus Pharmaceutical达成许可及商业化协议，推进Durvalumab和Emicizumab生物类似药在美及亚洲特定市场布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1123885510","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123885510?lang=zh_cn&edition=full","pubTime":"2026-08-21 21:01","pubTimestamp":1787317274,"startTime":"0","endTime":"0","summary":"Alvotech今日宣布，已与Lotus Pharmaceutical签署一项许可与商业化协议。该协议聚焦于两款拟议中的生物类似药——Durvalumab与Emicizumab，其市场覆盖范围包括美国及部分亚洲地区。此项合作标志着Alvotech在扩大其全球生物类似药管线方面迈出关键一步。根据协议条款，Lotus Pharmaceutical将负责上述产品在指定区域内的商业化推广，而Alvotech则继续主导研发与生产环节。协议的达成，进一步巩固了Alvotech作为生物类似药领域先行者的行业地位，同时也为Lotus Pharmaceutical拓宽其高价值产品组合提供了契机。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184507602","title":"Alvotech：管理层预计2026年总营收6.5亿至7亿美元，调整后EBITDA达1.8亿至2.2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184507602","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184507602?lang=zh_cn&edition=full","pubTime":"2026-08-20 04:35","pubTimestamp":1787171710,"startTime":"0","endTime":"0","summary":"Alvotech管理层披露了对2026财年的业绩展望。根据最新预测，公司预计全年总营收将落在6.5亿至7亿美元区间，同时调整后EBITDA有望达到1.8亿至2.2亿美元的水平。从营收端来看，这一指引区间较往年有显著提升，表明Alvotech正加快其产品管线的商业化步伐。而在盈利能力方面，调整后EBITDA的正向区间预期，则暗示着公司运营杠杆效应正逐步显现。管理层此番表态，为市场提供了清晰的业绩参照框架。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139131214","title":"财报前瞻｜Alvotech本季度营收预计小幅下滑，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1139131214","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139131214?lang=zh_cn&edition=full","pubTime":"2026-08-12 09:46","pubTimestamp":1786499206,"startTime":"0","endTime":"0","summary":"Alvotech将于2026年08月19日发布最新季度财报，市场关注公司收入结构与成本端进展对利润弹性的影响。当前一致预期显示，本季度Alvotech营收预计为1.11亿美元，同比下降7.88%；预计调整后每股收益为-0.03美元，同比改善10.00%；预计息税前利润为1,018.50万美元，同比下降60.92%。授权与里程碑回款对Alvotech的季度利润具有显著影响。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Alvotech本季度营收预计小幅下滑，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191997166","title":"Alvotech宣布拟进行1.25亿美元普通股公开发行及同步私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1191997166","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191997166?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:01","pubTimestamp":1781769704,"startTime":"0","endTime":"0","summary":"生物制药公司Alvotech近日披露了一项融资计划，拟通过公开发行普通股募集约1.25亿美元资金。与此同时，公司还计划开展一项并行的私募配售。\n该举措旨在为公司运营及管线发展提供资金支持。具体的发行条款，包括股票数量与定价，将根据市场情况最终确定。\nAlvotech专注于生物类似药的开发与商业化。此次融资计划若顺利实施，将为其全球业务拓展及研发活动注入新的资本动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106676454","title":"Alvotech 计划利用发行及私募配售净收益 推进生物类似药资产持续开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1106676454","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106676454?lang=zh_cn&edition=full","pubTime":"2026-06-16 04:02","pubTimestamp":1781553737,"startTime":"0","endTime":"0","summary":"Alvotech 宣布，其计划将本次公开发行及同步进行的私募配售所获得的净收益，全部用于支持公司旗下生物类似药资产的持续研发工作。此举旨在为关键管线的推进提供资金保障，加速产品开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152677619","title":"Alvotech宣布拟进行1.25亿美元普通股公开发行及同步私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1152677619","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152677619?lang=zh_cn&edition=full","pubTime":"2026-06-16 04:02","pubTimestamp":1781553737,"startTime":"0","endTime":"0","summary":"生物制药公司Alvotech宣布，计划进行总额1.25亿美元的普通股公开发行，并同步实施私募配售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146000160","title":"Alvotech宣布FDA受理其拟议可互换生物类似药Avt16的生物制品许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1146000160","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146000160?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:01","pubTimestamp":1780905690,"startTime":"0","endTime":"0","summary":"Alvotech公司宣布，美国食品药品监督管理局（FDA）已正式受理其生物制品许可申请（BLA），该申请针对的是其拟议产品Avt16。Avt16是一种旨在与Entyvio®进行互换的生物类似药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641164638","title":"Alvotech再次向FDA提交强生Simponi和再生元Eylea生物类似药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2641164638","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641164638?lang=zh_cn&edition=full","pubTime":"2026-06-05 03:16","pubTimestamp":1780600560,"startTime":"0","endTime":"0","summary":"冰岛生物制药公司Alvotech周四宣布，已再次向美国食品药品监督管理局提交两款生物类似药的生物制剂许可申请，分别针对强生的Simponi和再生元的Eylea。此次提交是与合作伙伴Teva共同推进的，标志着两家公司在拓展美国生物类似药市场方面迈出关键一步。AVT05是强生旗下Simponi及其静脉注射剂型Simponi Aria的生物类似药，该药属于肿瘤坏死因子阻滞剂，用于治疗类风湿关节炎、银屑病关节炎、强直性脊柱炎、溃疡性结肠炎等多种慢性炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-05/doc-iniahtfh8923892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BLSP4239.USD","LU2213496289.HKD","LU0882574055.USD","ALVO","IE00B1BXHZ80.USD","LU1066051225.USD","LU2417539215.USD","IE00BLSP4452.SGD","LU0689626769.HKD","BK4592","IE000F7OJYX1.SGD","LU0114720955.EUR","LU1244550577.SGD","SG9999001176.USD","LU1629891620.HKD","IE000SO60NU8.SGD","BK4007","IE000BZT7R73.USD","LU0545562505.USD","LU1261432733.SGD","IE00B3PB1722.GBP","LU0053666078.USD","LU1228905037.USD","LU2430703178.SGD","LU0432979614.USD","LU0203345920.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU2133065610.SGD","SG9999002232.USD","LU0964807845.USD","LU0683600562.USD","IE00B3T34201.USD","LU1121112475.USD","IE00BDGV0183.EUR","LU1074936037.SGD","BK4139","BK4588","LU1280957306.USD","LABU","LU1551013425.SGD","LU1894683348.USD","IE00B19Z3581.USD","IE00BN8TJ469.HKD","LU2750360641.GBP","JNJ","LU1585245621.USD","IPOS","LU1032466523.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138345689","title":"Alvotech宣布重新提交Avt05与Avt06在美生物制品许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1138345689","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138345689?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:01","pubTimestamp":1780560079,"startTime":"0","endTime":"0","summary":"Alvotech公司宣布，已重新向美国食品药品监督管理局提交了其生物类似药产品Avt05与Avt06的生物制品许可申请。\nAvt05是参照原研药Simponi®及Simponi Aria®开发的生物类似药候选产品。而Avt06则是参照原研药Eylea®开发的生物类似药候选产品。\n此次重新提交申请，标志着该公司在推动这些重要生物类似药于美国市场上市的过程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157608217","title":"Alvotech与Islandsbanki续签做市协议 其股票将继续在纳斯达克冰岛交易所交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1157608217","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157608217?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:32","pubTimestamp":1780302736,"startTime":"0","endTime":"0","summary":"Alvotech与Islandsbanki已就续签做市协议达成一致，该协议旨在为Alvotech股票在纳斯达克冰岛交易所的交易提供流动性支持。此举意味着，在Islandsbanki的持续做市服务下，Alvo股票的二级市场交易将获得更稳定的报价与更顺畅的交易体验。协议的续签反映了双方对维持该股票市场活跃度与效率的共同承诺，也旨在为投资者营造一个更具深度且可靠的交易环境。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162703760","title":"财报前瞻｜Alvotech本季度营收预计增48.23%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1162703760","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162703760?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:30","pubTimestamp":1777455012,"startTime":"0","endTime":"0","summary":"Alvotech将于2026年05月06日发布2026年第一季度财报，市场聚焦产品放量与费用结构变化对盈利的影响。市场一致预期本季度Alvotech营收约为1.41亿美元，同比增48.23%；调整后每股收益预计为0.02美元，同比增115.16%；息税前利润预计为3,233.67万美元，同比增361.31%。上一季度Alvotech实现营收1.69亿美元，同比增长10.14%；毛利率为63.72%；归属于母公司股东的净亏损为-1.09亿美元，净利率为-64.27%；调整后每股收益为-0.37美元，同比下降54.17%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Alvotech本季度营收预计增48.23%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518200082","title":"Alvotech C/Wts (To Pur Com)盘中异动 股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518200082?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:45","pubTimestamp":1741614350,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时45分，Alvotech C/Wts 股票出现异动，股价大幅下跌5.53%。Alvotech C/Wts 股票所在的制药行业中，整体跌幅为0.71%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 、大自然药业涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为209.63%、11.50%、4.30%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Sonoma Pharmaceuticals, Inc.、Alpha Teknova, Inc.，振幅分别为35.91%、30.15%、15.64%。Alvotech C/Wts 公司简介：Alvotech 是一家综合性生物制药公司，致力于为全球患者开发和制造高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214551a26a2a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214551a26a2a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVOW","BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517193759","title":"Alvotech盘中异动 股价大跌5.18%报10.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517193759?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:40","pubTimestamp":1741282856,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时40分，Alvotech股票出现异动，股价大幅下跌5.18%。截至发稿，该股报10.71美元/股，成交量5.2143万股，换手率0.02%，振幅2.79%。Alvotech股票所在的制药行业中，整体跌幅为1.57%。其相关个股中，博美集团、Cyclo Therapeutics, Inc.、惠普森医药涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、德纳维制药较为活跃，换手率分别为17.24%、9.27%、8.41%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Medicus Pharma Ltd.，振幅分别为33.03%、26.67%、21.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307014056963c6f04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307014056963c6f04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517928839","title":"Alvotech盘中异动 股价大涨5.04%报11.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517928839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517928839?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:10","pubTimestamp":1741198244,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时10分，Alvotech股票出现波动，股价快速上涨5.04%。截至发稿，该股报11.36美元/股，成交量5.5764万股，换手率0.02%，振幅3.33%。Alvotech股票所在的制药行业中，整体涨幅为0.42%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Organogenesis Holdings Inc.、坎伯兰药业涨幅较大，Painreform Ltd.、Petros Pharmaceuticals, Inc.、Cbdmd, Inc.较为活跃，换手率分别为22.96%、12.10%、8.42%，振幅较大的相关个股有坎伯兰药业、Alpha Teknova, Inc.、Organogenesis Holdings Inc.，振幅分别为27.93%、16.89%、15.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021044989d7632&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021044989d7632&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517438489","title":"Alvotech C/Wts (To Pur Com)盘中异动 急速拉升10.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517438489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517438489?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:00","pubTimestamp":1741186800,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时00分，Alvotech C/Wts 股票出现波动，股价急速上涨10.24%。Alvotech C/Wts 股票所在的制药行业中，整体涨幅为0.51%。其相关个股中，Medicus Pharma Ltd.、Organogenesis Holdings Inc.、Sunshine Biopharma Inc.涨幅较大，Petros Pharmaceuticals, Inc.、Inmed Pharmaceuticals Inc.、大自然药业较为活跃，换手率分别为4.72%、2.06%、1.02%，振幅较大的相关个股有Alpha Teknova, Inc.、Medicus Pharma Ltd.、Inmed Pharmaceuticals Inc.，振幅分别为16.72%、14.66%、11.61%。Alvotech C/Wts 公司简介：Alvotech 是一家综合性生物制药公司，致力于为全球患者开发和制造高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230000989d4c53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230000989d4c53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVOW","BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516672736","title":"Alvotech C/Wts (To Pur Com)盘中异动 早盘股价大跌8.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516672736?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098778,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Alvotech C/Wts 股票出现波动，股价快速下挫8.64%。Alvotech C/Wts 股票所在的制药行业中，整体跌幅为0.02%。其相关个股中，脑再生科技、Evoke Pharma, Inc.、Esperion Therapeutics, Inc.涨幅较大，大自然药业、Petros Pharmaceuticals, Inc.、Quantum Biopharma Ltd.较为活跃，换手率分别为3.01%、1.25%、1.00%，振幅较大的相关个股有Ani Pharmaceuticals, Inc.、Medicus Pharma Ltd.、Therapeuticsmd, Inc.，振幅分别为6.77%、5.00%、4.90%。Alvotech C/Wts 公司简介：Alvotech 是一家综合性生物制药公司，致力于为全球患者开发和制造高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223258a25f0518&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223258a25f0518&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVOW","BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516653169","title":"Alvotech C/Wts (To Pur Com)盘中异动 快速下挫5.75%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516653169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516653169?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:45","pubTimestamp":1741016742,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时45分，Alvotech C/Wts 股票出现异动，股价快速跳水5.75%。Alvotech C/Wts 股票所在的制药行业中，整体涨幅为0.55%。其相关个股中，坎伯兰药业、Kiniksa Pharmaceuticals, Ltd.、Intercure Ltd.涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、大自然药业较为活跃，换手率分别为13.10%、7.92%、6.42%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Cyclo Therapeutics Inc C/Wts 11/12/2025、坎伯兰药业，振幅分别为35.16%、18.12%、17.49%。Alvotech C/Wts 公司简介：Alvotech 是一家综合性生物制药公司，致力于为全球患者开发和制造高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032345439637bf1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032345439637bf1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVO","BK4139","ALVOW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516421379","title":"Alvotech C/Wts (To Pur Com)股价重挫12.13% 市值跌1425.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516421379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516421379?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:14","pubTimestamp":1740759265,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时14分，Alvotech C/Wts 股票出现异动，股价急速下挫12.13%。截至发稿，该股报2.10美元/股，成交量2334股，换手率0.00%，振幅14.23%。Alvotech C/Wts 股票所在的制药行业中，整体跌幅为0.26%。Alvotech C/Wts 公司简介：Alvotech 是一家综合性生物制药公司，致力于为全球患者开发和制造高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100142598968fc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100142598968fc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVOW","BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514914386","title":"Alvotech C/Wts (To Pur Com)盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514914386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514914386?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:52","pubTimestamp":1740667939,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时52分，Alvotech C/Wts 股票出现波动，股价急速拉升5.06%。Alvotech C/Wts 股票所在的制药行业中，整体涨幅为0.92%。其相关个股中，Medicus Pharma Ltd.、Ironwood医药、Optinose, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、Quantum Biopharma Ltd.较为活跃，换手率分别为18.72%、9.57%、4.44%，振幅较大的相关个股有Cyclo Therapeutics Inc C/Wts 11/12/2025、Petros Pharmaceuticals, Inc.、Quantum Biopharma Ltd.，振幅分别为20.58%、20.25%、11.27%。Alvotech C/Wts 公司简介：Alvotech 是一家综合性生物制药公司，致力于为全球患者开发和制造高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225219abdf7402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225219abdf7402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALVOW","ALVO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alvotech.com","stockEarnings":[{"period":"1week","weight":-0.084},{"period":"1month","weight":-0.2117},{"period":"3month","weight":0.4967},{"period":"6month","weight":0.355},{"period":"1year","weight":-0.438},{"period":"ytd","weight":-0.1072}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alvotech于2021年8月23日根据卢森堡大公国法律注册成立。该公司是一家生物技术公司，由Robert Wessman创立，专注于为全球患者开发和制造生物仿制药。该公司通过提供高质量、具有成本效益的产品和服务，通过完全集成的方法和广泛的内部能力来寻求成为生物仿制药领域的全球领导者。该公司目前的产品线包含八种生物仿制药候选药物，旨在治疗自身免疫性疾病、眼部疾病、骨质疏松症、呼吸系统疾病和癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.097473},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.03925},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.102535},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.043688},{"month":5,"riseRate":0.5,"avgChangeRate":0.044095},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.079133},{"month":7,"riseRate":0.333333,"avgChangeRate":0.050089},{"month":8,"riseRate":0.5,"avgChangeRate":0.048501},{"month":9,"riseRate":0.5,"avgChangeRate":-0.029746},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.04723},{"month":11,"riseRate":0.6,"avgChangeRate":-0.068468},{"month":12,"riseRate":0.833333,"avgChangeRate":0.164022}],"exchange":"NASDAQ","name":"Alvotech","nameEN":"Alvotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alvotech(ALVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alvotech(ALVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alvotech,ALVO,Alvotech股票,Alvotech股票老虎,Alvotech股票老虎国际,Alvotech行情,Alvotech股票行情,Alvotech股价,Alvotech股市,Alvotech股票价格,Alvotech股票交易,Alvotech股票购买,Alvotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alvotech(ALVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alvotech(ALVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}